The global synthetic genomics market is slated to be valued at US$ 30.3 billion at the end of 2023. During the assessment period ranging from 2023 to 2033, a CAGR of 12.6% is anticipated for the industry, with an estimated market value of US$ 99.6 billion. In this world of synthetic biology, synthetic genomics is still in the infant stage. Synthetic genomics is the disruptive technology at the heart of Bio-economy. Technological advancement in synthetic genomics has raised the bar for excellence and have taken the competition to the next level. Scientists are exploring newer approaches for treating life-threatening diseases.
For instance, use of genetically engineered viruses to correct defective genes in the patients with the genetically inherited disease will bring the new transformation in the healthcare, credit goes to Synthetic Genomics market. Synthetic genomics demonstrates better understanding of deadly diseases and propels the rapid production of vaccines. Apart from healthcare, synthetic genomics finds its application in today’s sustainability challenges in the fields like renewable energy, nutrition and human health. For instance, developing genetically modified algal strains as a renewable source of energy will drive the future of synthetic genomics.
Synthetic genomics owes a lot to synthetic biology, making use of much of methods resources and jargon involved, yet it differs in crucial ways too. Synthetic biology - a major new interdisciplinary subject that has emerged this century - is focused on rewriting and reprogramming the DNA in cells using cycles of design and engineering to get improvements. It aspires to do this using engineering principles such as modularity and standardisation that enable researchers to more quickly get to the ultimate aim of tailoring cells as technologies for specific tasks. Currently, synthetic genomics lacks these formalities, as its goal is not to optimise one cell behaviour over the rest but to produce a new understanding of DNA and biology, either directly or by enabling new experiments.
In spite of it being a relatively niche field, a number of healthcare providers are specializing in offering synthetic genomics for various applications. SynCTI, for instance, is part of the Synthetic Yeast 2.0 (Sc2.0) consortium working towards the construction of the first eukaryotic cell with a functional fully synthetic genome. A prominent feature of Sc2.0 is the incorporation of an in-built genome evolution system named SCRaMbLE that enables on-demand rearrangement of the synthetic genome. This platform allows generation of large mutant libraries that can be screened for strains of desired characteristics. Using this system, we aim to isolate and study a host of yeast variants to address fundamental biological questions along with developing novel biotechnological applications.
Among all applications, the food industry is expected to generate significant prospects. Synthetic genomics is likely to help detect food spoilage organisms through the use of bionanotechnology. Food spoilage post-harvest represent a significant issue in the food production industry. For example, it is estimated that in potato production a large processing house can lose over £100,000 purely from soft potato rot. A key part of addressing this issue is the development of new rapid test systems that can identify sources of microbial contamination in incoming vegetables and hence prevent spread within the facility.
Countries such as the United Kingdom are continually trying to reduce the use of animal testing in research, both for ethical reasons and because there are limits in the usefulness of animal-based data in predicting human safety. New testing methods, based on growing human tissues and organs in culture, might provide a more effective and ethical alternative to animal tests. Synthetic genomics is expected to facilitate this objective.
| Data Points | Key Statistics |
|---|---|
| Expected 2023 Market Value | US$ 30.3 billion |
| Anticipated 2033 Market Value | US$ 99.6 billion |
| Global Growth Rate (2023 to 2033) | CAGR of 12.6% |
In this world of synthetic biology, synthetic genomics is still in the infant stage. Synthetic genomics is the disruptive technology at the heart of Bio-economy. Technological advancement in synthetic genomics has raised the bar for excellence and have taken the competition to the next level. Scientists are exploring newer approaches for treating life-threatening diseases.
For instance, use of genetically engineered viruses to correct defective genes in the patients with the genetically inherited disease will bring the new transformation in the healthcare, credit goes to Synthetic Genomics market. Synthetic genomics demonstrates better understanding of deadly diseases and propels the rapid production of vaccines.
Apart from healthcare, synthetic genomics finds its application in today’s sustainability challenges in the fields like renewable energy, nutrition and human health. For instance, Developing genetically modified algal strains as a renewable source of energy will drive the future of Synthetic genomics.
The capability of Synthetic genomics in providing a solution to Global Healthcare, Agriculture, Manufacturing and environmental challenges will fuel the growth coupled with recent technological advancements. Decreased cost of DNA sequencing and DNA synthesis will boost the research and trigger commercialization of synthetic genomics market.
The chemical and biological threats along with ethical concerns prove to be the restraints for the Synthetic genomics field. Custom DNA synthesis along with functional genomics of Pathogens can be a threat. Adding to this, risk assessment of the purely entirely synthetic organism will become more challenging.
In 2017 ExxonMobil and Synthetic Genomics achieved a milestone in algae biofuel research that is expected to fuel the growth of the market. For instance, algae strain developed by synthetic genomics doubled oil production. Simultaneously attempts are being made to develop food proteins and oils from Non-engineered algal strains using Synthetic Genomic technology.
Exploitation of synthetic genomics to synthesize enzymes used in manufacturing of drugs is the unique approach that will take the field to new heights. For instance, United kingdom based GlaxoSmithKline (GSK) is developing living system that can produce molecules like Aspirin, that comes from chemical process rather than biological process.
Synthetic genomics will change the conventional research methodologies. For instance, it will assist in synthesizing difficult sequences that include high GC content, repetitive pattern and Centromere. Synthetic Genomic will enable synthesis of large sequence (1000+base pair) in one go instead of assembling the multiple shorter sequences.
Development of Synthetic probiotics and genetic engineering to the pigs to make them Virus resistant and have Immune-profiles similar to Human are the future trends of Synthetic.
Firms operating in synthetic genomics segment, are focusing on expanding their product portfolio. As a part of this strategy, in 2017, Genscript Biotech one of the leading and most innovative firm acquired CustomArray. Another giant Ginkgo Bioworks has acquired leading synthetic DNA provider Gen9.
Technological advancement in North America in Synthetic biology will boost the Synthetic Genomic market in the USA and Canada. The potential for Synthetic Genomics Market is high in Europe due to increased number of organ donation and Transplantation and well-placed healthcare payer-provider structure.
Asia-Pacific is expected to show significant growth for Synthetic Genomics Market due to higher antibiotic resistance in India and other developing nations. Latin America and the Middle East and Africa region will show slower growth for Synthetic Genomics Market owing to lack of awareness amongst the people in this region.
Examples of some of the market participants in Synthetic Genomics Market identified across the value chain are: Synthetic Genomics Inc., Integrated DNA Technologies Inc., Thermo Fisher Scientific Inc., GenScript, Biocompare Inc., Twist Bioscience, Boster Biological Technology, Genewiz, Eurofins Genomics.
The research report on Synthetic Genomics Market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report on Synthetic Genomics Market provides analysis and information according to market segments such as geographies, application, and industry.
The report on Synthetic Genomics Market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global Synthetic Genomics Market is classified on the basis of Product, application and end user
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Synthetic Dye Market Forecast Outlook 2025 to 2035
Synthetic Data Generation Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Biology Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Abrasives Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Zeolite Y Adsorbent Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Musk Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Tackifiers Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Spider Silk Proteins Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Synthetic Polymer Wax Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Aperture Radar (SAR) Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Diamond Market Size and Share Forecast Outlook 2025 to 2035
Genomics Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Turf Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Food Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Polyisoprene Rubber Market Report – Trends & Innovations 2025–2035
Synthetic and Bio Emulsion Polymer Market Size and Share Forecast Outlook 2025 to 2035
Synthetic And Bio Based PMMA Polymethyl Methacrylate Size Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Quartz Market Size and Share Forecast Outlook 2025 to 2035
Synthetic Leather Market Forecast & Growth 2025 to 2035
Synthetic Quartz Industry Analysis in Japan - Size, Share, & Forecast Outlook 2025 to 2035
Synthetic Genomics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
